Title | Current Controversies in Bone Marrow Transplantation [electronic resource] / edited by Brian J. Bolwell |
---|---|
Imprint | Totowa, NJ : Humana Press : Imprint: Humana Press, 2000 |
Connect to | http://dx.doi.org/10.1007/978-1-59259-657-7 |
Descript | XIV, 322 p. online resource |
I. Transplant Strategies -- 1 How Many Stem Cells Are Sufficient for Engraftment? -- 2 Is Bone Marrow Transplantation Appropriate in Older Patients? -- 3 What Is an Accurate Risk/Benefit Ratio for Umbilical Cord Cell Transplantation in Children and Adults? -- 4 Are Busulfan-Based Preparative Regimens Equivalent, Worse, or Better than Total Body Irradiation Regimens? -- 5 Is Total Body Irradiation Necessary in Bone Marrow Transplantation for Pediatric ALL? -- II. Transplantation for Hematologic Malignancies -- 6 Stem Cell Transplantation for Chronic Myeloid Leukemia: Indications and Timing -- 7 Should All Adult Patients with Acute Lymphoblastic Leukemia in First Remission Undergo Allogeneic Bone Marrow Transplantation? -- 8 What Is the Curative Potential of Refractory Leukemia with Related and Unrelated Allogeneic Transplants? -- 9 What Is the Role of Autologous Stem Cell Transplantation for Leukemia? -- 10 Autologous Transplantation for Hodgkinโs Disease: Who Benefits? -- 11 Hematopoietic Stem Cell Transplantation for Mantle Cell Lymphoma -- 12 Is Autologous Transplantation for Non-Hodgkinโs Lymphoma Underutilized? -- III. Transplantation for Solid Tumors -- 13 Do Patients Benefit from Autotransplants for Advanced Ovarian Cancer? -- 14 What Is the Optimal Timing of Autologous Transplantation for Metastatic Breast Cancer? -- 15 Should All Patients with Inflammatory Breast Cancer Undergo Autologous Stem Cell Transplant? -- 16 High-Dose Chemotherapy with Stem Cell Rescue for Germ Cell Cancer? -- IV. Complications of Transplantation -- 17 Graft-vs-Host Disease: Has Any Progress Been Made in the Past Decade? -- 18 Veno-occlusive Disease of the Liver: Does Anything Really Work? -- 19 Myelodysplasia and Acute Leukemia Following High-Dose Chemotherapy -- 20 Can Aspergillus Infections Be Prevented in Allogeneic Bone Marrow Transplant Recipients? -- 21 Prevention of Cytomegalovirus Infection After Allogeneic Bone Marrow Transplantation